Browsing by Subject Hepatitis C

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 10 to 29 of 60 < previous   next >
Issue DateTitleAuthor(s)
9-May-2019Changes to the national strategies, plans and guidelines for the treatment of hepatitis C in people who inject drugs between 2013 and 2016: a cross-sectional survey of 34 European countriesMaticic, Mojca; Zorman, Jerneja Videcnik; Gregorcic, Sergeja; Schatz, Eberhard; Lazarus, Jeffrey V.
7-May-2017Cost-effectiveness of nehanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patientsSoto, Marcelo; Sampietro-Colom, Laura; Lasalvia, Luis; Mira, Aurea; Jiménez Povedano, Wladimiro; Navasa, Miquel
25-Jan-2020Direct-acting antiviral therapy improves kidney survival in hepatitis C virus-associated cryoglobulinaemia: the RENALCRYOGLOBULINEMIC studyPérez de José, Ana; Carbayo, Javier; Pocurull, Anna; Bada Bosch, Teresa; Cases Corona, Clara Maria; Shabaka, Amir; Ramos Terrada, Natàlia; Martínez Valenzuela, Laura; Huerta, Ana; Fernandez Lorente, Loreto; Malek Marín, Tamara Gelen; Goicoechea, Marian
29-Mar-2017Direct-acting antivirals for hepatitis C virus induce a rapid clinical and biochemical remission of porphyria cutanea tardaCombalia, Andrea; To i Figueras, Jordi; Laguno Centeno, Montserrat; Martínez Rebollar, María; Aguilera, Paula
Jun-2016Educació farmacèutica en el tractament de l'hepatitis cBoixareu Balagué, Núria; Closa Granados, Paula; Garcia Rodriguez, Cristina; Gol Viayna, Maria; Justo López, Andrea; Mulet Bayona, Juanvi; Rouco Carmona, Iria; Ruiz Boy, Sònia; Sánchez Preto, Ariadna; Tusell Rabassa, Maria; Xixons Dordal, Josep
24-Sep-2019Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice - Vie-KinD studyLondoño, María Carlota; Riveiro Barciela, Mar; Ahumada, Adriana; Muñoz Gómez, Raquel; Roget, Mercé; Devesa Medina, María J.; Serra, Miguel Ángel; Navascués, Carmen A.; Baliellas Comellas, Mª Carme; Aldamiz, Teresa; Gutiérrez, María L.; Polo Lorduy, Benjamín; Carmona, Isabel; Benlloch, Salvador; Bonet, Lucía; García Samaniego, Javier; Jiménez Pérez, Miguel; Morán Sánchez, Senador; Castro, Ángeles; Delgado, Manuel; Gea Rodríguez, Francisco; Martín Granizo, Ignacio; Montes, María Luisa; Morano, Luís; Castaño, Manuel A.; Santos, Ignacio de los; Laguno Centeno, Montserrat; Losa, Juan Emilio; Montero-Alonso, Marta; Rivero, Antonio; Álvaro, Cristina de; Manzanares, Amanda; Mallolas Masferrer, Josep; Barril, Guillermina; González Parra, Emilio; García Buey, Luisa
20-May-2017Efficacy and safety of direct-acting antiviral agents when combined with secukinumabMartínez Santana, Virginia; Rodríguez Murphy, Esther; Smithson Amat, Alejandro; Miserachs Aranda, Nuria; Río-Gil, Ruben del; Torre Lloverás, Inmaculada
19-Apr-2006Efficacy and safety of Pegylated Interferon-α2b Plus Ribavirin for the treatment of chronic hepatitis C in HIV-infected patientsSantín Cerezales, Miguel; Shaw Perujo, Evelyn; Garcia, Maria Jose; Delejido, Antonio; Rodríguez de Castro, Eduardo; Rota Roca, Rosa; Altés, Jordi; Baguena, Francisco; Valero, Silvia; Sala, Montserrat; Casanova Rituerto, Aurora; HCV/HIV-01 Study Team
Apr-2020Eliminating Hepatitis C Virus From a Prevalent Kidney Transplant Recipient Population: A Single-Center Study in Belgium in the Direct-Acting Antivirals EraDevresse, Arnaud; Delire, Bénédicte; Lazarus, Jeffrey V.; Kabamba, Benoit; Meyer, Martine De; Mourad, Michel; Buemi, Antoine; Darius, Tom; Cambier, Jean-François; Goffin, Eric; Jadoul, Michel; Kanaan, Nada
27-Feb-2020Eliminating viral hepatitis C in Belgium: the micro-elimination approachBusschots, Dana; Toghanian, Samira; Bielen, Rob; Salomonsson, Stina; Koc, Özgür M.; Hendrickx, Greet; Jadoul, Michel; Nevens, Frederick; Sokal, Etienne; Brixko, Christian; Peerlinck, Kathelijne; Apers, Ludwig; Robaeys, Geert; Lazarus, Jeffrey V.
5-Jul-2013Estudi de la incidència, factors de risc (sociodemogràfics, clínics i genètics), i resposta al tractament profilàctic amb antidepressius de la depressió induïda per interferó alfa en la hepatitis C crònicaUdina i Bonet, Marc
1-Oct-2022Granuloma Annulare: a case-control study of possible associated diseasesFornons Servent, Rosa; Bauer Alonso, Andrea; Llobera-Ris, Clàudia; Penín, Rosa; Marcoval Caus, Joaquim
11-May-2018Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countriesBielen, Rob; Stumo, Samya R.; Halford, Rachel; Werling, Klára; Reic, Tatjana; Stover, Heino; Robaeys, Geert; Lazarus, Jeffrey V.
Dec-2022HCV microelimination in harm reduction centres has benefits beyond HCV cure but is hampered by high reinfection ratesLens, Sabela; Miralpeix, Anna; Gálvez, Mont; Martró, Elisa; González, Noemí; Rodríguez Tajes, Sergio; Mariño, Zoe; Saludes, Verónica; Reyes Urueña, Juliana; Majó, Xavier; Colom, Joan; Forns, Xavier
Apr-2008Hepatitis C and Non-Hodgkin Lymphoma Among 4784 Cases and 6269 Controls From the International Lymphoma Epidemiology ConsortiumSanjosé Llongueras, Silvia de; Benavente, Yolanda; Vajdic, Claire M.; Engels, Eric A.; Morton, Lindsay M.; Bracci, Paige M.; Spinelli, John J.; Zheng, Tongzhang; Zhang, Yawei; Franceschi, Silvia; Talamini, Renato; Holly, Elizabeth A.; Grulich, Andrew E.; Cerhan, James R.; Hartge, Patricia; Cozen, Wendy; Boffetta, Paolo; Brennan, Paul; Maynadié, Marc; Cocco, Pierluigi; Bosch, Ramon; Foretova, Lenka; Staines, Anthony; Becker, Nikolaus; Nieters, Alexandra
1-Jan-2018Hepatitis C infection substantially reduces survival of alcohol-dependent patientsMuga, Roberto; Sanvisens, Arantza; Jarrin, Inmaculada; Fuster, Daniel; Bolao, Ferran; Tor, Jordi; Muñoz, Alvaro
2020Hepatitis C prevalence in Denmark in 2016-An updated estimate using multiple national registersNielsen, Stine; Hansen, Janne Fuglsang; Hay, Gordon; Cowan, Susan; Jepsen, Peter; Omland,Lars Haukali; Krarup, Henrik Bygum; Søholm, Jacob; Lazarus, Jeffrey V.; Weis, Nina; Øvrehus, Anne; Christensen, Peer Brehm
21-Jul-2018Hepatitis C seropositivity among newly incarcerated prisoners in Estonia: data analysis of electronic health records from 2014 to 2015Kivimets, Kristel; Uusküla, Anneli; Lazarus, Jeffrey V.; Ott, Kristi
21-Mar-2019Hepatitis C services at harm reduction centres in the European Union: a 28-country surveyPericàs, Juan M.; Bromberg, Daniel J.; Ocampo, Denise; Schatz, Eberhard; Wawer, Iwona; Wysocki, Piotr; Safreed-Harmon, Kelly; Lazarus, Jeffrey V.
14-Dec-2001Hepatitis C tras el trasplante hepático: Historia natural y factores de riesgo de evolución desfavorable.Berenguer Haym, Marina